Meeder Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Meeder Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7	Closed	-$1K	–	2393
2020 Q4	$1K	Sell	7 -20	-74%	-$2.45K	﹤0.01%	1651
2020 Q3	$4K	Hold	27	–	–	﹤0.01%	1646
2020 Q2	$5K	Sell	27 -24	-47%	-$4.97K	﹤0.01%	1517
2020 Q1	$10K	Buy	51 +1	+2%	+$215	﹤0.01%	1512
2019 Q4	$10K	Buy	+50	New	+$9.24K	﹤0.01%	1555

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Meeder Asset Management's LKFT Position: Q1 2021 in Review

Meeder Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2021, closing a stake of 7 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in LKFT in Q4 2019 and held it in 5 quarters. The position peaked at $10K in Q1 2020. 132 funds tracked by Wall St. Rank hold LKFT as of Q1 2021.

Meeder Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Meeder Asset Management sold 7 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2021, an estimated $1K.
Meeder Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 5 quarters.
Meeder Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $10K in Q1 2020.
132 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2021.

Based on Meeder Asset Management's 13F filing for Q1 2021, filed 28 Apr 2021.